Efficacy and Safety of PD-1 Inhibitor Combined with Anlotinib on Advanced Neuroendocrine Carcinoma
Objective To analyze the efficacy and safety of PD-1 inhibitor combined with anlotinib on advanced neuroendocrine carcinoma. Methods We collected the data of patients with advanced neuroendocrine carcinoma who had failed the first-line standard chemotherapy and treated with PD-1 inhibitor combined w...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | ZH |
| Publié: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/186b970ee9bb445ab2de5a5302123faf |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|